Guardant Health Partners With Agostino Gemelli University Polyclinic Foundation To Launch In-House Liquid Biopsy Testing Service Using Guardant360 CDx At Policlinico Gemelli Facilities In Rome, Italy
Portfolio Pulse from Benzinga Newsdesk
Guardant Health has partnered with Agostino Gemelli University Polyclinic Foundation to introduce an in-house liquid biopsy testing service using Guardant360 CDx at Policlinico Gemelli in Rome, Italy.
September 10, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health has entered a partnership with Agostino Gemelli University Polyclinic Foundation to offer liquid biopsy testing using Guardant360 CDx in Rome, potentially expanding its market reach and enhancing its service offerings.
The partnership with a major medical institution in Rome could lead to increased adoption of Guardant360 CDx, enhancing Guardant Health's market presence in Europe. This strategic move is likely to positively impact GH's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90